newsfilter
← Latest News
GlobeNewswire·

Supernus to Participate in the TD Cowen 45th Annual Health Care Conference

ROCKVILLE, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system